OTHER GROUP COMPANIES
market

Vaishali Pharma stock jumps 6% after launching Immunity booster products

Currently, the Company has launched its Immunity booster products in different countries.

June 14, 2021 3:13 IST | India Infoline News Service
Vaishali Pharma Limited has launched worldwide, its series of Immunity booster products such as Vipravita C (tablets and effervescent), Vipravita CZ (tablets), Vipravita D3, Viprafolic A, Vipravita, Vipramultivita, Ascorzee (tablet), Herbal Cough drops, Viprasure (powder), Vipra C (Gummies), Vipra B (Gummies), Vipra M (Gummies), Multi-Vitamin (effervescent), Women D (effervescent), ), to improve immunity and fight against disease-causing germs like bacteria, COVID -19 viruses, parasites or fungi etc.

Currently, the Company has launched its Immunity booster products in different countries.

The company said that its products have made their grasp on the overseas market and getting excellent feedback worldwide. The Company is showing consistent agility and innovation by meeting the needs of its customers in both Domestic and International markets.

At around 3.10 PM, Vaishali Pharma was trading at Rs44.25 per piece up by 5.61% on NSE.

OPEN A DEMAT ACCOUNT & Get FREE Benefits worth 10,000

OPEN A DEMAT ACCOUNT & Get
FREE Benefits worth 10,000

STOCK VIEW

PRESTIGE (NSE)

The average score for Prestige Estates Projects Limited stands at 4 against 6, three months back.

Prestige Estates Projects Limited is engaged in the business of real estate development. The Company’s principal products/services include Development and construction

FEATURED ARTICLE

BLOGS

Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity